Pharming (PHAR) Receivables - Net (2019 - 2026)
Pharming's (PHAR) quarterly Receivables - Net came in at $57.0 million in Q2 2026, up 6.85% YoY from $53.3 million in Q2 2025, and down 5.09% on a QoQ basis from $60.0 million in Q1 2026.
Pharming (PHAR) Receivables - Net (2019 - 2026) Analysis & Trends
Pharming (PHAR) has 8 years of Receivables - Net data on file, last reported at $57.0 million in Q2 2026.
- Quarterly Receivables - Net rose 6.85% year-over-year to $57.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $57.0 million (up 6.85% YoY) and the FY2025 annual result came in at $54.7 million, changed 0.22% from the prior year.
- Receivables - Net eased to $57.0 million in Q2 2026, from $60.0 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $60.0 million in Q1 2026 to a low of $28828.0 in Q3 2022.
- A 5-year average of $41.9 million and a median of $44.9 million in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2022 — Receivables - Net sank 99.91% — and 2023, when it soared 140461.26%.
- Tracing PHAR's Receivables - Net over 5 years: stood at $27.6 million in 2022, then jumped by 67.12% to $46.2 million in 2023, then gained by 18.77% to $54.8 million in 2024, then dropped by 0.22% to $54.7 million in 2025, then climbed by 4.16% to $57.0 million in 2026.
- The last three Receivables - Net figures came in at $57.0 million (Q2 2026), $60.0 million (Q1 2026), and $54.7 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.98 Mn |
| Jun 30, 2026 | 56.98 Mn |
| Mar 31, 2026 | 60.03 Mn |
| Mar 31, 2026 | 60.03 Mn |
| Dec 31, 2025 | 54.70 Mn |
| Dec 31, 2025 | 54.70 Mn |
| Sep 30, 2025 | 43.61 Mn |
| Sep 30, 2025 | 43.61 Mn |
| Jun 30, 2025 | 53.33 Mn |
| Jun 30, 2025 | 53.33 Mn |
| Mar 31, 2025 | 47.49 Mn |
| Mar 31, 2025 | 47.49 Mn |
| Dec 31, 2024 | 54.82 Mn |
| Dec 31, 2024 | 54.82 Mn |
| Sep 30, 2024 | 48.20 Mn |
| Sep 30, 2024 | 48.20 Mn |
| Jun 30, 2024 | 51.12 Mn |
| Jun 30, 2024 | 51.12 Mn |
| Mar 31, 2024 | 38.70 Mn |
| Mar 31, 2024 | 38.70 Mn |